Published in Schizophr Res Treatment on June 30, 2014
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry (2003) 10.07
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20
Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med (1999) 5.48
Neurobiology of schizophrenia. Neuron (2006) 3.69
The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 3.68
Mental disorder, intellectual deficiency, and crime. Evidence from a birth cohort. Arch Gen Psychiatry (1992) 3.28
Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol (2006) 2.73
Trends in ethnopharmocology. J Ethnopharmacol (2005) 2.51
Traditional knowledge of Kani tribals in Kouthalai of Tirunelveli hills, Tamil Nadu, India. J Ethnopharmacol (2005) 2.34
Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry (2005) 2.08
Mental disorder and crime. Evidence from a Danish birth cohort. Arch Gen Psychiatry (1996) 1.97
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry (2012) 1.77
Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res (2005) 1.76
The use of medicinal plants in the trans-Himalayan arid zone of Mustang district, Nepal. J Ethnobiol Ethnomed (2010) 1.60
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci (2004) 1.48
Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychopathol (2001) 1.48
Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr (2011) 1.45
Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience (1999) 1.25
Linkage and associated studies of schizophrenia. Am J Med Genet (2000) 1.16
Medicinal plants used for treatment of diabetes by the Marakh sect of the Garo tribe living in Mymensingh district, Bangladesh. Afr J Tradit Complement Altern Med (2012) 1.14
Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology (2005) 1.13
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
Potential medicinal plants for CNS disorders: an overview. Phytother Res (2006) 1.10
Schizophrenia and city residence. Br J Psychiatry Suppl (1994) 1.08
What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr Opin Psychiatry (2006) 1.06
A survey of medicinal plants used by Kavirajes of Chalna area, Khulna district, Bangladesh. Afr J Tradit Complement Altern Med (2009) 1.06
Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytother Res (2007) 1.00
A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. Clin Neuropharmacol (1989) 0.99
The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis. Br J Psychiatry (2005) 0.97
Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Drug Test Anal (2012) 0.96
Medicinal plants and formulations used by the Soren clan of the Santal tribe in Rajshahi district, Bangladesh for treatment of various ailments. Afr J Tradit Complement Altern Med (2012) 0.93
Complementary and alternative medicine use by psychiatric inpatients. Psychol Rep (2005) 0.92
Antipsychotic-like activity of noni (Morinda citrifolia Linn.) in mice. BMC Complement Altern Med (2012) 0.90
Anxiolytic and antidepressant activities of methanol extract of Aegle marmelos leaves in mice. Indian J Physiol Pharmacol (2011) 0.90
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Curr Pharm Des (2012) 0.89
Medicinal plants used by various tribes of bangladesh for treatment of malaria. Malar Res Treat (2012) 0.89
Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue. Postgrad Med J (2002) 0.81
The evolution of the serotonin-dopamine antagonist concept. J Clin Psychopharmacol (1995) 0.80
Meeting report; "Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis," April 11-14, 1999. Biol Psychiatry (2000) 0.78
Psychopharmacological profile of hydro-alcoholic extract of Euphorbia neriifolia leaves in mice and rats. Indian J Exp Biol (2005) 0.78
Biochemical studies in schizophrenia. Schizophr Bull (1976) 0.77
Complementary and alternative medicine in the treatment of schizophrenia. Psychiatr Danub (2009) 0.77